591 Comparison of two oHSV Vectors for the treatment of glioblastoma

591 Comparison of two oHSV Vectors for the treatment of glioblastoma

Bibliographic Details
Main Authors:	Joseph Jackson, Bonnie Hall, Lisa Bailey, E Chiocca, Justus Cohen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
by: Joseph W. Jackson, et al.
Published: (2021-09-01)

GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival
by: Paola Sette, et al.
Published: (2019-12-01)

STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation
by: Joel M. Lee, et al.
Published: (2019-12-01)

Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV
by: Tatiana Gianni, et al.
Published: (2021-09-01)

oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity
by: Wen Zhang, et al.
Published: (2020-03-01)

CASACIÓN Nº 591-2016 –HUAURA
by: Cabello Silva, Andrea Fernanda
Published: (2021)

Immunotherapeutic Efficacy of Retargeted oHSVs Designed for Propagation in an Ad Hoc Cell Line
by: Andrea Vannini, et al.
Published: (2021-01-01)

Engineered HSV vector achieves safe long-term transgene expression in the central nervous system
by: Gianluca Verlengia, et al.
Published: (2017-05-01)

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
by: Yoshitaka Miyagawa, et al.
Published: (2017-09-01)

Urban civilians' experiences in the Romano-Persian wars, 502-591 CE
by: Fan Chiang, Shih-Cong
Published: (2015)

Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies
by: Ceren Tuzmen, et al.
Published: (2020-03-01)

La posible vigencia del artículo 1.591 del Código Civil
by: José Manuel Fernández Hierro
Published: (2015-01-01)

Influence of shear bands on the landslide of 59.1k, Tai-18 Highway
by: Hung-Yuan Chang, et al.
Published: (2012)

Aurintricarboxylic acid increases yield of HSV-1 vectors
by: Peter Pechan, et al.
Published: (2014-01-01)

Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes
by: Seiji Kuroda, et al.
Published: (2020-06-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
by: Marilin S. Koch, et al.
Published: (2020-11-01)

Development of HSV-1 vectors for applications in the peripheral nervous system
by: Branston, Ruth Helen
Published: (2001)

Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1
by: LaPointe Gisèle, et al.
Published: (2011-04-01)

Investigation of the Establishment and Decline of Āl-Shomleh Local Government (550-591 AH) In Seljuk Khuzestan
by: Lida Mavadat, et al.
Published: (2021-03-01)

Herpes Simplex Virus (HSV-1) Encephalitis Mimicking Glioblastoma: Case Report and Review of the Literature
by: Burke A. Cunha, et al.
Published: (2014-12-01)

Comparison between two diagnostic system such analyzer I and RAD 120 for the determination of IgG and IgM for HSV-1 and HSV-2
by: Annelisa Borelli, et al.
Published: (2010-09-01)

The use of HSV-1 vectors for transgene expression in the mammalian nervous system
by: Raza, Mansoor
Published: (2007)

Prandi, Reginaldo. Mitologia dos orixás, São Paulo, Companhia das Letras, 2001, 591 pp.
by: Andreas Hofbauer
Published: (2001-01-01)

Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
by: Xiaolan Cheng, et al.
Published: (2017-06-01)

HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part I. HSV-1 Structure, Replication and Pathogenesis
by: Andreas Jacobs, et al.
Published: (1999-11-01)

STAT3 activation promotes oncolytic HSV1 replication in glioma cells.
by: Kazuo Okemoto, et al.
Published: (2013-01-01)

Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas
by: Dileep D. Monie, et al.
Published: (2021-05-01)

Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
by: Claudia Del Vecchio, et al.
Published: (2019-03-01)

Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia.
by: Clara Lina Salazar, et al.
Published: (2018-01-01)

Strategies in Gene Therapy for Glioblastoma
by: Mariano S. Viapiano, et al.
Published: (2013-10-01)

An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain
by: Bonnie Reinhart, et al.
Published: (2016-01-01)

Словник "Исторической Палеи" по списку синодального собрания № 591 второй половины ХV века – глоттометрическая характеристика
by: Татяна Илиева
Published: (2015-08-01)

Cruse, Romain. Une géographie populaire de la Caraïbe, Montréal : Mémoires d’encrier, 2014, 591 p.
by: Djemaa Maazouzi
Published: (2018-04-01)

BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
by: Laura Cortesi, et al.
Published: (2021-05-01)

Autotransplantation in mdx Mice of mdx Myoblasts Genetically Corrected by an HSV-1 Amplicon Vector
by: Mathieu Bujold, et al.
Published: (2002-11-01)

Rotavirus VP6 protein expressed in cell culture by HSV-1-based vectors
by: Carlos A Palacios, et al.
Published: (2015-03-01)

Genomic Heterogeneity of Glioblastoma: A Comparison of the Enhancing Tumor Core and the Brain Around the Tumor
by: Barbee, Bonnie
Published: (2016)

Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
by: Oleg Mozhei, et al.
Published: (2020-12-01)

HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and Applications
by: Andreas Jacobs, et al.
Published: (1999-11-01)